Kaushik Ghoshal - Oct 11, 2024 Form 4 Insider Report for RESMED INC (RMD)

Signature
Kaushik Ghoshal, Chief Commercial Officer, SaaS business
Stock symbol
RMD
Transactions as of
Oct 11, 2024
Transactions value $
-$582,938
Form type
4
Date filed
10/15/2024, 10:06 AM
Previous filing
Sep 13, 2024
Next filing
Nov 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $433K +4.26K +19.55% $101.64 26K Oct 11, 2024 Direct F1
transaction RMD ResMed Common Stock Sale -$1.02M -4.26K -16.35% $238.48 21.8K Oct 11, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -4.26K -100% $0.00 0 Oct 11, 2024 ResMed Common Stock 4.26K $101.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024.
F2 Represents date options first became exercisable. Options vest 1/3 per year.